liquid biopsy market – Global Outlook and Forecast 2023-2029 is latest research study released by Allied Market Research evaluating the market risk side analysis, highlighting opportunities and leveraged with strategic and tactical decision-making support (2023-2029). The market Study is segmented by key a region that is accelerating the marketization. The report provides information on market research and development, growth drivers, and the changing investment structure of the Global Liquid Biopsy Market.

Global Liquid Biopsy Market was valued at USD 1.32 billion in 2021 and is expected to reach USD 4.79 billion by the year 2028, at a CAGR of 20.2%.

Read More:

Some of the key players profiled in the study are:

  • Hoffmann-La Roche Ltd. (Switzerland)
  • Myriad Genetics Inc. (US)
  • QIAGEN N.V. (Netherlands)
  • Thermo Fisher Scientific Inc. (the US)
  • Guardant Health Inc. (the US)
  • BIOCEPT Inc. (the US)
  • Illumina Inc. (the US)
  • Angle plc (UK)
  • Oncimmune(UK)
  • Lucence health Inc. (US)
  • FreenomeHoldings Inc. (US) and Other Major Players.

Liquid Biopsy Market: Demand Analysis & Opportunity Outlook 2029

Liquid Biopsy research study defines market size of various segments & countries by historical years and forecast the values for next 6 years. The report is assembled to comprise qualitative and quantitative elements of Liquid Biopsy industry including: market share, market size (value and volume 2017-2022, and forecast to 2029) that admires each country concerned in the competitive marketplace. Further, the study also caters and provides in-depth statistics about the crucial elements of Liquid Biopsy which includes drivers & restraining factors that helps estimate future growth outlook of the market.

See also  A Step-by-Step Guide to Becoming a Pharmacovigilance Expert

Have Any Query? Ask Our Expert @:

The segments and sub-section of Liquid Biopsy market is shown below:

By Cancer Type

  • Lung
  • Breast
  • Liver
  • Others

By Circulating Biomarker

  • Circulating Tumor DNA
  • Circulating Tumor Cells
  • Others

By End-User

  • Hospitals
  • Laboratories
  • Government Research Centre

Download Free Sample:

By Region

  • North America (U.S., Canada, Mexico)
  • Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
  • Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
  • Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
  • South America (Brazil, Argentina, Rest of SA)

Covid-19 Impact Analysis On Liquid Biopsy Market

The global pandemic of COVID-19 has slowed the growth rate of the liquid biopsy market from 2020 to 2021. The novel influenza coronavirus (SARS-CoV-2) has disrupted many aspects of our lives, including medical activities. In this setting, much routine cancer diagnostic and therapeutic procedures have been suspended, leading to delays in diagnosis, treatments, and, ultimately, increases in cancer mortality rates. Equally drastic has been the impact of COVID-19 on clinical trials. The pandemic has also impacted the logistics and supplies of cancer diagnostic raw materials and components and other essential commodities utilized in the assembly of liquid biopsy. These factors limit the growth of the liquid biopsy market during the COVID-19 pandemic.

Reasons to buy

  • Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
  • Recognize emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
  • Classify potential new clients or partners in the target demographic.
  • Develop tactical initiatives by understanding the focus areas of leading companies.
  • Plan mergers and acquisitions meritoriously by identifying Top Manufacturers.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and Scope.
See also  MEMS Mirrors Market - Growth, Trends, Covid-19 Impact, And Forecasts (2029 - 2029)

Read More Related Report:

Buy-Now this Premium Report (𝐔𝐩 𝐭𝐨 𝟕𝟎% 𝐃𝐢𝐬𝐜𝐨𝐮𝐧𝐭):

About us:

Introspective Market Research ( is a visionary research consulting firm dedicated to assist our clients grow and have a successful impact on the market. Our team at IMR is ready to assist our clients flourish their business by offering strategies to gain success and monopoly in their respective fields. We are a global market research company, specialized in using big data and advanced analytics to show the bigger picture of the market trends. We help our clients to think differently and build better tomorrow for all of us. We are a technology-driven research company, we analyze extremely large sets of data to discover deeper insights and provide conclusive consulting. We not only provide intelligence solutions, but we help our clients in how they can achieve their goals.

Contact us:

Introspective Market Research

3001 S King Drive,

Chicago, Illinois

60616 USA

Ph no: +1-773-382-1049


LinkedIn | Twitter | Facebook